Cynthia Clayton

Cynthia Clayton is an experienced professional in biotechnology communications and investor relations, currently serving as the Vice President of Communications & Investor Relations at Third Rock Ventures.1 She has held this position since May 2019.2

Career History

Cynthia has a long-standing career in the biotechnology industry:

• Third Rock Ventures: She joined the company in October 2015 as Head of Communications, later becoming Head of Communications and Investor Relations in January 2018, before assuming her current role.2

• Alnylam Pharmaceuticals: Prior to Third Rock Ventures, she worked at Alnylam for nearly a decade, starting as Senior Director of Investor Relations and Corporate Communications in 2005 and eventually becoming Vice President of Investor Relations and Corporate Communications.2

• Previous Roles: She has also held positions at Synta Pharmaceuticals and Millennium Pharmaceuticals in investor relations and corporate communications.2

Responsibilities at Third Rock Ventures

At Third Rock Ventures, Cynthia leads the company's communications strategy and initiatives. She works closely with portfolio companies, guiding them on their communications and investor relations strategies.1

Education and Background

Cynthia holds a B.A. in Communications from the University of Hartford.12

Personal Approach

Cynthia is known for her commitment to the life-changing work in the biotechnology industry. Despite not having a scientific background, she values the opportunities she's had to learn from mentors and colleagues with extensive scientific expertise. She appreciates the dedication and focus of her colleagues at Third Rock Ventures in creating impactful companies for patients and their families.1

Cynthia Clayton's LinkedIn username is cynthiaclayton, as specified in the query.2